Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
4,287 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00893555 | Pharmacologic Optimization of Voriconazole(VORI911) | completed | Phase 3 | 189 | Jan-Willem C AlffenaarOTHER | 1 | Jan 12, 2017 | clinicaltrials |
| NCT00405756 | A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. | completed | Phase 3 | 459 | Celgene CorporationINDUSTRY | 22 | Jan 11, 2017 | clinicaltrials |
| NCT01469793 | A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer | completed | Phase 1 | 71 | Genentech, Inc.INDUSTRY | 2 | Jan 10, 2017 | clinicaltrials |
| NCT01828489 | Research Study for Treatment of Children and Adolescents With Acute Myeloid Leukaemia 0-18 Years(AML2012) | unknown | Phase 3 | 300 | Vastra Gotaland RegionOTHER_GOV | 9 | Jan 10, 2017 | clinicaltrials |
| NCT01974752 | Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT)(SUMIT) | completed | Phase 3 | 152 | AstraZenecaINDUSTRY | 11 | Jan 5, 2017 | clinicaltrials |
| NCT00777153 | Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma(REGAL) | completed | Phase 3 | 423 | AstraZenecaINDUSTRY | 10 | Dec 28, 2016 | clinicaltrials |
| NCT01374451 | Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET(COOPERATE-2) | terminated | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 19 | Dec 20, 2016 | clinicaltrials |
| NCT02075905 | Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management | completed | — | 111 | University of North Carolina, Chapel HillOTHER | 3 | Dec 20, 2016 | clinicaltrials |
| NCT02997449 | Complete Endosonographic Intrathoracic Nodal Staging of Lung Cancer Patients in Whom SABR is Considered | unknown | — | 102 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 2 | Dec 20, 2016 | clinicaltrials |
| NCT00456807 | Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years | completed | Phase 3 | 100 | GlaxoSmithKlineINDUSTRY | 1 | Dec 16, 2016 | clinicaltrials |
| NCT01895673 | PET-MRI After Radiofrequency Ablation (RFA) or Microwave Ablation (MWA) | completed | — | 20 | dr. M.P. van den Tol MD PhDOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT01690377 | Natural Dendritic Cell Vaccines in Metastatic Melanoma Patients | completed | Phase 1 | 30 | Radboud University Medical CenterOTHER | 1 | Dec 8, 2016 | clinicaltrials |
| NCT01369329 | A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1) | completed | Phase 3 | 769 | Janssen Research & Development, LLCINDUSTRY | 23 | Dec 7, 2016 | clinicaltrials |
| NCT00039338 | Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | unknown | Phase 3 | 686 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Dec 5, 2016 | clinicaltrials |
| NCT01091584 | Nurse Intervention Project(VIP) | completed | N/A | 193 | Radboud University Medical CenterOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT01549535 | Polyp Detection With The Peerscope System™ | completed | Phase 2 | 197 | PeerMedical Ltd.INDUSTRY | 3 | Nov 25, 2016 | clinicaltrials |
| NCT02465814 | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids(ASTEROID 2) | completed | Phase 2 | 120 | BayerINDUSTRY | 16 | Nov 22, 2016 | clinicaltrials |
| NCT01609920 | Nodal Staging in Breast Cancer With MRL | terminated | N/A | 97 | Maastricht University Medical CenterOTHER | 1 | Nov 10, 2016 | clinicaltrials |
| NCT02208804 | Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization(SIM) | unknown | Phase 2 / Phase 3 | 25 | UMC UtrechtOTHER | 1 | Nov 9, 2016 | clinicaltrials |
| NCT00903175 | Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma(RECORD-3) | completed | Phase 2 | 471 | Novartis PharmaceuticalsINDUSTRY | 19 | Nov 8, 2016 | clinicaltrials |
| NCT02288130 | Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy(MYOMEX) | unknown | Phase 4 | 100 | Amsterdam UMC, location VUmcOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT00776698 | A Study of Avastin (Bevacizumab) in Combination With Thoracic Radiation and Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer. | completed | Phase 1 | 1 | Hoffmann-La RocheINDUSTRY | 2 | Nov 2, 2016 | clinicaltrials |
| NCT00975182 | A Study of the Safety and Pharmacology of GDC-0941 in Combination With Erlotinib in Patients With Advanced Solid Tumors | completed | Phase 1 | 58 | Genentech, Inc.INDUSTRY | 2 | Nov 2, 2016 | clinicaltrials |
| NCT01070927 | An Exploratory Study of RO4929097 in Patients With Recurrent or Refractory Non-Small Cell Lung Cancer | completed | Phase 2 | 7 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01358903 | A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors | completed | Phase 1 | 65 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT01383733 | A Study of RO5458640 in Patients With Advanced Solid Tumors | completed | Phase 1 | 54 | Hoffmann-La RocheINDUSTRY | 3 | Nov 2, 2016 | clinicaltrials |
| NCT01462175 | A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia | completed | Phase 1 | 99 | Hoffmann-La RocheINDUSTRY | 5 | Nov 2, 2016 | clinicaltrials |
| NCT01849666 | A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy | completed | Phase 1 | 2 | Hoffmann-La RocheINDUSTRY | 5 | Nov 2, 2016 | clinicaltrials |
| NCT01851824 | A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy | completed | Phase 1 | 9 | Hoffmann-La RocheINDUSTRY | 9 | Nov 2, 2016 | clinicaltrials |
| NCT02485626 | Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors(HARBOR) | unknown | — | 628 | The Netherlands Cancer InstituteOTHER | 1 | Oct 31, 2016 | clinicaltrials |
| NCT02657044 | EMR Versus ESD for Resection of Large Distal Non-pedunculated Colorectal Adenomas(MATILDA) | unknown | N/A | 212 | UMC UtrechtOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT02916992 | Prevalence of Spontaneous Pneumothorax in BHD | unknown | Phase 1 | 200 | Hans SmitOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT00367588 | Low Bacterial Diet in Patients With Cytopenia | completed | N/A | 20 | Maastricht University Medical CenterOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT00565188 | Application of ATP Infusions in Palliative Home Care | completed | Phase 3 | 100 | Maastricht University Medical CenterOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT01717443 | Genital HPV Infections Before and After Renal Transplantation | completed | — | 65 | University Medical Center NijmegenOTHER | 1 | Oct 25, 2016 | clinicaltrials |
| NCT01188187 | Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer(SYNERGY) | completed | Phase 3 | 1,022 | Achieve Life SciencesINDUSTRY | 12 | Oct 14, 2016 | clinicaltrials |
| NCT01894256 | Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function | completed | Phase 1 | 56 | AstraZenecaINDUSTRY | 5 | Oct 13, 2016 | clinicaltrials |
| NCT00182819 | Radiation Therapy or Temozolomide in Treating Patients With Gliomas | completed | Phase 3 | 709 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 19 | Oct 12, 2016 | clinicaltrials |
| NCT01508000 | Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases(BOS2) | terminated | Phase 2 | 44 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Oct 12, 2016 | clinicaltrials |
| NCT00949910 | An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 4 | 6,586 | Hoffmann-La RocheINDUSTRY | 51 | Oct 5, 2016 | clinicaltrials |
| NCT00312377 | ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer(ZODIAC) | completed | Phase 3 | 1,690 | Genzyme, a Sanofi CompanyINDUSTRY | 25 | Sep 30, 2016 | clinicaltrials |
| NCT00404924 | ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures | completed | Phase 3 | 1,140 | Genzyme, a Sanofi CompanyINDUSTRY | 22 | Sep 30, 2016 | clinicaltrials |
| NCT00861614 | Study of Immunotherapy to Treat Advanced Prostate Cancer | completed | Phase 3 | 988 | Bristol-Myers SquibbINDUSTRY | 27 | Sep 30, 2016 | clinicaltrials |
| NCT01949259 | Rapid Learning for Lung Cancer | completed | — | 10,000 | Maastricht Radiation OncologyOTHER | 1 | Sep 30, 2016 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials